Search research articles
Contact Us
Filters
Showing results (11-20 of 19) with videos related to
Page
of 2
Sort By:
You have reached the last page of results.
This site can display upto 19 results.
Scientific Reports
|
February 10, 2021
Astrocytic expression of the Alzheimer's disease risk allele, ApoEε4, potentiates neuronal tau pathology in multiple preclinical models
Angela Marie Jablonski, Lee Warren, Marija Usenovic, et al.
The Journal of Surgical Research
|
October 15, 2025
Efficacy and Outcomes of Nitinol Covered Stents for Management of Acute Iatrogenic and Secondary Esophageal Perforation
Vignesh Vudatha, Elizabeth Bashian, Renee Cholyway, et al.
Neurochemical Research
|
August 4, 2009
Genome-wide microarray analysis of the differential neuroprotective effects of antioxidants in neuroblastoma cells overexpressing the familial Parkinson's disease alpha-synuclein A53T mutation
Lei Ma, Tracy T Cao, Geeta Kandpal, et al.
Bioorganic & Medicinal Chemistry Letters
|
August 6, 2016
Optimization of microtubule affinity regulating kinase (MARK) inhibitors with improved physical properties
David L Sloman, Njamkou Noucti, Michael D Altman, et al.
Bioorganic & Medicinal Chemistry Letters
|
November 30, 2016
MARK inhibitors: Declaring a No-Go decision on a chemical series based on extensive DMPK experimentation
Andrew M Haidle, Kaleen K Childers, Anna A Zabierek, et al.
The Journal of Pharmacology and Experimental Therapeutics
|
February 26, 2020
Pharmacological Characterization of the Novel and Selective <i>α</i>7 Nicotinic Acetylcholine Receptor-Positive Allosteric Modulator BNC375
Xiaohai Wang, Christopher Daley, Vanita Gakhar, et al.
Bioorganic & Medicinal Chemistry Letters
|
November 7, 2016
Structure guided design of a series of selective pyrrolopyrimidinone MARK inhibitors
Jason D Katz, Andrew Haidle, Kaleen K Childers, et al.
ACS Chemical Biology
|
December 30, 2016
Iterative Focused Screening with Biological Fingerprints Identifies Selective Asc-1 Inhibitors Distinct from Traditional High Throughput Screening
Peter S Kutchukian, Lee Warren, Brian C Magliaro, et al.
The Journal of Pharmacology and Experimental Therapeutics
|
March 31, 2004
Generation and characterization of a human bradykinin receptor B1 transgenic rat as a pharmacodynamic model
J Fred Hess, Richard W Ransom, Zhizhen Zeng, et al.
Page
of 2
Search research articles
Search
Showing results (11-20 of 19) with videos related to
Sort By:
Page
of 2
You have reached the last page of results.
This site can display upto 19 results.
Scientific Reports
|
February 10, 2021
Astrocytic expression of the Alzheimer's disease risk allele, ApoEε4, potentiates neuronal tau pathology in multiple preclinical models
Angela Marie Jablonski, Lee Warren, Marija Usenovic, et al.
The Journal of Surgical Research
|
October 15, 2025
Efficacy and Outcomes of Nitinol Covered Stents for Management of Acute Iatrogenic and Secondary Esophageal Perforation
Vignesh Vudatha, Elizabeth Bashian, Renee Cholyway, et al.
Neurochemical Research
|
August 4, 2009
Genome-wide microarray analysis of the differential neuroprotective effects of antioxidants in neuroblastoma cells overexpressing the familial Parkinson's disease alpha-synuclein A53T mutation
Lei Ma, Tracy T Cao, Geeta Kandpal, et al.
Bioorganic & Medicinal Chemistry Letters
|
August 6, 2016
Optimization of microtubule affinity regulating kinase (MARK) inhibitors with improved physical properties
David L Sloman, Njamkou Noucti, Michael D Altman, et al.
Bioorganic & Medicinal Chemistry Letters
|
November 30, 2016
MARK inhibitors: Declaring a No-Go decision on a chemical series based on extensive DMPK experimentation
Andrew M Haidle, Kaleen K Childers, Anna A Zabierek, et al.
The Journal of Pharmacology and Experimental Therapeutics
|
February 26, 2020
Pharmacological Characterization of the Novel and Selective <i>α</i>7 Nicotinic Acetylcholine Receptor-Positive Allosteric Modulator BNC375
Xiaohai Wang, Christopher Daley, Vanita Gakhar, et al.
Bioorganic & Medicinal Chemistry Letters
|
November 7, 2016
Structure guided design of a series of selective pyrrolopyrimidinone MARK inhibitors
Jason D Katz, Andrew Haidle, Kaleen K Childers, et al.
ACS Chemical Biology
|
December 30, 2016
Iterative Focused Screening with Biological Fingerprints Identifies Selective Asc-1 Inhibitors Distinct from Traditional High Throughput Screening
Peter S Kutchukian, Lee Warren, Brian C Magliaro, et al.
The Journal of Pharmacology and Experimental Therapeutics
|
March 31, 2004
Generation and characterization of a human bradykinin receptor B1 transgenic rat as a pharmacodynamic model
J Fred Hess, Richard W Ransom, Zhizhen Zeng, et al.
Page
of 2